Back
Speaker illustration

Doctor Concetta Crivera

Janssen Scientific Affairs, LLC, Raritan, NJ (United States of America)

Presentations

Risk of venous thromboembolism recurrences in patients who continued versus discontinued rivaroxaban therapy after an initial six-month therapy

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Antithrombotics in daily clinical practice

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources